1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Refractory Chronic Cough: new trials by email Literature Review of Refractory Chronic Cough trials Research Report on Refractory Chronic Cough
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough BLU-5937, Placebo - Cough, Refractory Chronic Cough | Phase 3 | Completed | Bellus Health Inc. - a GSK company | 957 | 2022-10-25 | 2026-07-14 |
Chronic Cough (1) · Cough (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1) · Signs and Symptoms, Respiratory (1)
Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
BLU-5937 (1)
Bellus Health Inc. - a GSK company (1)
Argentina (1) · Belgium (1) · Canada (1) · Colombia (1) · France (1) · Hungary (1) · India (1) · Israel (1) · Netherlands (1) · Poland (1) · South Africa (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)